Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
6538.0000
-14.00
(
-0.21
%)
NSE
May 22, 2025
15:31 PM
New 52W High in past week
Volume:
327.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
13 Aug 2022
6538.00
-0.21%
Divi's Labs (HOLD): No respite in sight for margins
Hold:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 4250
BOB Capital Markets Ltd.
Q1 revenue broadly in line with consensus at Rs 22.5bn (+15% YoY/-10% QoQ), but EBITDA 10% below
Divi's Laboratories .. has an
average target
of 5832.12 from 9 brokers.
More from Divi's Laboratories Ltd.
Recommended
Market closes lower, Strides Pharma's Q4 net profit surges 5x YoY to Rs 113 crore
Trendlyne Marketwatch |
22 May 2025, 03:59PM
From grid to gains: Transformer makers electrify the market
The Baseline |
21 May 2025, 10:23AM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022